6gdz - Revision history

OCA at 13:31, 10 May 2019

OCA — Fri, 10 May 2019 13:31:18 GMT

←Older revision		Revision as of 13:31, 10 May 2019
Line 1:		Line 1:

	==exendin-4 based dual GLP-1/glucagon receptor agonist==		==exendin-4 based dual GLP-1/glucagon receptor agonist==
-	<StructureSection load='6gdz' size='340' side='right' caption='[[6gdz]], [[NMR_Ensembles_of_Models \| 10 NMR models]]' scene=''>	+	<StructureSection load='6gdz' size='340' side='right'caption='[[6gdz]], [[NMR_Ensembles_of_Models \| 10 NMR models]]' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[6gdz]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GDZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GDZ FirstGlance]. <br>		<table><tr><td colspan='2'>[[6gdz]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GDZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GDZ FirstGlance]. <br>
Line 23:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Evers, A]]		[[Category: Evers, A]]
	[[Category: Kurz, M]]		[[Category: Kurz, M]]
	[[Category: Hormone]]		[[Category: Hormone]]

OCA at 05:56, 20 June 2018

OCA — Wed, 20 Jun 2018 05:56:20 GMT

←Older revision		Revision as of 05:56, 20 June 2018
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6gdz is ~~ON HOLD~~	+	==exendin-4 based dual GLP-1/glucagon receptor agonist==
		+	<StructureSection load='6gdz' size='340' side='right' caption='[[6gdz]], [[NMR_Ensembles_of_Models \| 10 NMR models]]' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[6gdz]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GDZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GDZ FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EVT:(2~{S})-2-[[(4~{S})-4-(hexadecanoylamino)-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]pentanedioic+acid'>EVT</scene></td></tr>
		+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=AIB:ALPHA-AMINOISOBUTYRIC+ACID'>AIB</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6gdz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6gdz OCA], [http://pdbe.org/6gdz PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6gdz RCSB], [http://www.ebi.ac.uk/pdbsum/6gdz PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6gdz ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/EXE4_HELSU EXE4_HELSU]] Venom protein that mimics the incretin hormone glucagon-like peptide 1 (GLP-1). It stimulates insulin synthesis and secretion, protects against beta-cell apoptosis in response to different insults, and promotes beta-cell proliferation. It also promotes satiety, reduces food intake, reduces fat deposition, reduces body weight and inhibits gastric emptying. Interacts with GLP-1 receptor (GLP1R). Induces hypotension that is mediated by relaxation of cardiac smooth muscle.<ref>PMID:8405712</ref> <ref>PMID:19837656</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Novel peptidic dual agonists of the glucagon-like peptide 1 (GLP-1) and glucagon receptor are reported to have enhanced efficacy over pure GLP-1 receptor agonists with regard to treatment of obesity and diabetes. We describe novel exendin-4 based dual agonists designed with an activity ratio favoring the GLP-1 versus the glucagon receptor. As result of an iterative optimization procedure that included molecular modeling, structural biological studies (X-ray, NMR), peptide design & synthesis, experimental activity and solubility profiling, a candidate molecule was identified. Novel SAR points are reported that allowed to fine-tune the desired receptor activity ratio and increased solubility in the presence of antimicrobial preservatives - findings which can be of general applicability for any peptide discovery project. The peptide was evaluated in chronic in vivo studies in obese diabetic monkeys as translational model for the human situation and demonstrated favorable blood glucose and body weight lowering effects.

-	~~Authors: Evers~~, A., Kurz, M.	+	Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multi-dose Formulations.,Evers A, Bossart M, Pfeiffer-Marek S, Elvert R, Schreuder HA, Kurz M, Stengelin S, Lorenz M, Herling A, Konkar AA, Lukasczyk U, Pfenninger A, Lorenz K, Haack T, Kadereit D, Wagner M J Med Chem. 2018 Jun 7. doi: 10.1021/acs.jmedchem.8b00292. PMID:29879354<ref>PMID:29879354</ref>

-	~~Description: exendin~~-~~4 based dual GLP~~-1/~~glucagon receptor agonist~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	~~[[Category: Unreleased Structures]]~~	+	</div>
-	~~[[Category: Kurz, M]]~~	+	<div class="pdbe-citations 6gdz" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Evers, A]]		[[Category: Evers, A]]
		+	[[Category: Kurz, M]]
		+	[[Category: Hormone]]

OCA: Protected "6gdz" [edit=sysop:move=sysop]

OCA — Wed, 02 May 2018 06:55:29 GMT

Protected "6gdz" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:55, 2 May 2018

OCA: New page: '''Unreleased structure''' The entry 6gdz is ON HOLD Authors: Evers, A., Kurz, M. Description: exendin-4 based dual GLP-1/glucagon receptor agonist Category: Unreleased Structures ...

OCA — Wed, 02 May 2018 06:55:28 GMT

New page: '''Unreleased structure''' The entry 6gdz is ON HOLD Authors: Evers, A., Kurz, M. Description: exendin-4 based dual GLP-1/glucagon receptor agonist Category: Unreleased Structures ...

New page

'''Unreleased structure'''

The entry 6gdz is ON HOLD

Authors: Evers, A., Kurz, M.

Description: exendin-4 based dual GLP-1/glucagon receptor agonist
[[Category: Unreleased Structures]]
[[Category: Kurz, M]]
[[Category: Evers, A]]